PRIMARY STUDY

Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy

Key Findings:  Compared to healthy subjects, this study found that urinary levels of liver-type fatty acid-binding protein (l-FABP) were associated with worsening diabetic nephropathy. Treatment with pitavastatin may help ameliorate tubulointerstitial damage in early diabetic nephropathy.